OTC - ACTIVE INGREDIENT SECTION
| Each tablet contains: Sennosides 8.6 mg |
| Each tablet contains: Sennosides 8.6 mg |
| Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away |
PURPOSE: LAXATIVE |
| Relieves occasional constipation (irregularity;generally causes bowel movement in 6-12 hours |
Directions:
Take preferably at bedtime or as directed by a doctor; if you do not have a comfortable bowel movement by the second day, increase dose by one tablet (do not exceed maximum dosage) or decrease dose until you are comfortable. Adults and children 12 years and over - starting dosage: 2 tablets once a day Maximum dosage: 4 tablets twice a day Children 6 to under 12 years - starting dosage: 1 tablet once a day Maximum dosage: 2 tablets twice a day Children 2 to under 6 years - starting dosage: 1/2 tablet once a day Maximum dosage: 1 tablet twice a day Children under 2 years - ask a doctor |
| WARNINGS: Do not use laxative products for longer than 1 week unless directed by a doctor |
| Inactive Ingredients: croscarmellose sodium, dibasic calcium phosphate dihydrate, hypromellose, magnesium stearate, microcrystalline cellulose, mineral oil |
Product: 63739-431
NDC: 63739-431-10 10 TABLET, COATED in a BLISTER PACK / 10 in a BOX, UNIT-DOSE
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 63739-431-10 | 2020-07-22 | C162847 | 48780-1 | ab0e2407-2600-f274-e053-dbdaa90a6471 | 7a0b096b-ab37-4ffd-8d88-7f91e6ed60da |
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 49483-080-01 | EA - Each | 49483-080 | 2a975f41-459c-40f7-bd31-b959b44eb14d | 1 | 2012-07-24 |
| 49483-080-10 | EA - Each | 49483-080 | 13d69fcc-a762-4953-9a30-e27716d917a0 | 1 | 2012-07-24 |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| SENNOSIDES | ACTIVE INGREDIENT | 3FYP5M0IJX | 1 | |
| SENNOSIDES | ACTIVE MOIETY | 3FYP5M0IJX | 1 | |
| CELLULOSE, MICROCRYSTALLINE | INACTIVE INGREDIENT | OP1R32D61U | 1 | |
| CROSCARMELLOSE SODIUM | INACTIVE INGREDIENT | M28OL1HH48 | 1 | |
| DIBASIC CALCIUM PHOSPHATE DIHYDRATE | INACTIVE INGREDIENT | O7TSZ97GEP | 1 | |
| HYPROMELLOSE | INACTIVE INGREDIENT | 3NXW29V3WO | 1 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | 1 | |
| MINERAL OIL | INACTIVE INGREDIENT | T5L8T28FGP | 1 | |
| STARCH, TAPIOCA | INACTIVE INGREDIENT | 24SC3U704I | 1 | |
| TARTARIC ACID | INACTIVE INGREDIENT | W4888I119H | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 63739-431 | 63739-431-10 |
| 49483-080 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| CROSCARMELLOSE SODIUM | M28OL1HH48 | IACT |
| DIBASIC CALCIUM PHOSPHATE DIHYDRATE | O7TSZ97GEP | IACT |
| HYPROMELLOSE, UNSPECIFIED | 3NXW29V3WO | IACT |
| MAGNESIUM STEARATE | 70097M6I30 | IACT |
| MICROCRYSTALLINE CELLULOSE | OP1R32D61U | IACT |
| MINERAL OIL | T5L8T28FGP | IACT |
| SENNOSIDES A AND B | 1B5FPI42EN | ACTIB |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| CROSCARMELLOSE SODIUM | CROSCARMELLOSE SODIUM | M28OL1HH48 | TABLET, COATED / ORAL | 224 mg | ||
| DIBASIC CALCIUM PHOSPHATE DIHYDRATE | DIBASIC CALCIUM PHOSPHATE DIHYDRATE | O7TSZ97GEP | TABLET, COATED / ORAL | 488.7 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, COATED / ORAL | 920 mg | ||
| STARCH, TAPIOCA | STARCH, TAPIOCA | 24SC3U704I | CAPSULE / ORAL | 100 mg | ||
| TARTARIC ACID | TARTARIC ACID | W4888I119H | TABLET, COATED / ORAL | 10 mg | ||
| STARCH, TAPIOCA | STARCH, TAPIOCA | 24SC3U704I | TABLET / ORAL | 5 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET, COATED / ORAL | 184 mg | ||
| HYPROMELLOSE | HYPROMELLOSE | 3NXW29V3WO | TABLET, COATED / ORAL | 58 mg | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | TABLET, COATED / ORAL | 1.5 mg |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| SENNA TIME | SENNOSIDES | TIME CAP LABORATORIES, INC | 18ec8127-422c-4c1a-8331-58dabce69969 | 2025-02-08 | Warnings | 49483-080 |
| bd229f16-8662-d63a-e053-2995a90a6f84 | 7a0b096b-ab37-4ffd-8d88-7f91e6ed60da | 2021-03-09 | Warnings | 7a0b096b-ab37-4ffd-8d88-7f91e6ed60da |
Adverse event summaries are temporarily unavailable. Other product information remains available.